Inactive Instrument
Mymetics Corporation Stock Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 439K 386K 356K 333K 623K 41.41M 635K 4.27M 1.65M 20.42M 1.65M 1.61M 70.99M | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 72.12M 63.47M 58.46M 54.69M 102M 6.81B 104M 702M 271M 3.36B 271M 265M 11.67B | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2012-11-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| +4.43% | +0.21% | +60.07% | +115.25% | 52.88B | |
| +1.58% | +19.37% | +75.37% | +85.18% | 50.98B | |
| -0.23% | -2.41% | -14.36% | -16.00% | 22.81B | |
| +0.98% | +6.11% | -1.35% | +423.40% | 22.43B | |
| +2.03% | +10.85% | +30.31% | -12.32% | 17.01B | |
| +0.88% | +5.07% | +28.91% | -34.26% | 15.91B | |
| +0.68% | +1.51% | +16.43% | +168.03% | 13.29B | |
| +3.02% | +18.32% | +141.11% | +308.04% | 13.58B | |
| +0.79% | +2.79% | +80.29% | +116.18% | 11.75B | |
| Average | +0.36% | +4.59% | +46.31% | +128.17% | 24.52B | |
| Weighted average by Cap. | +1.96% | +4.49% | +48.56% | +120.53% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 430K 378K 349K 326K 610K 40.59M 623K 4.18M 1.62M 20.01M 1.61M 1.58M 69.57M | 1.03M 905K 833K 780K 1.46M 97.03M 1.49M 10M 3.87M 47.84M 3.86M 3.78M 166M |
| Net income | -4.73M -4.16M -3.83M -3.59M -6.72M -446M -6.85M -46.02M -17.8M -220M -17.76M -17.37M -765M | -4.8M -4.23M -3.89M -3.64M -6.82M -454M -6.96M -46.75M -18.08M -224M -18.04M -17.65M -777M |
| Net Debt | 67.1M 59.05M 54.39M 50.88M 95.26M 6.33B 97.15M 653M 253M 3.12B 252M 246M 10.86B | 71.68M 63.08M 58.1M 54.36M 102M 6.77B 104M 697M 270M 3.34B 269M 263M 11.6B |
Employees
-
